The Board of Trustees of the Leland Stanford Junior University
发明人:
Nicholas J. Leeper,Irving L. Weissman
申请号：
US15551881
公开号：
US20180028651A1
申请日:
2016.02.25
申请国别(地区):
US
年份:
2018
代理人:
摘要：
An effective combined dose of an anti-CD47 agent and an anti-TNF agent is administered to the subject in a dose and for a period of time effective to stabilize, prevent or reduce atherosclerotic plaque in the individual.
